Revolution Medicines RVMD
NASDAQ RVMD
$192.28 +14.63 (+8.24%)
At close: Nov 6, 2026 · 4:00 PM EST

Revolution Medicines (RVMD) Change in Accrued Expenses (2019 - 2026)

Updated

Revolution Medicines (RVMD) reported Change in Accrued Expenses of $55.78 million for Q2 2026, up 415.6% from $10.82 million a year earlier.

Analysis

Revolution Medicines (RVMD) Change in Accrued Expenses (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Revolution Medicines' Change in Accrued Expenses came in at $138.94 million, up 239.3% year-over-year; for FY2025, it was $112.27 million, up 410.7% from FY2024.

  • Change in Accrued Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 87.4% (FY2020 to FY2025).
  • By year, Change in Accrued Expenses came in at $21.99 million in FY2024 (+49.9%), $14.67 million in FY2023 (+876.6%), $1.5 million in FY2022 (-82.8%) and $8.72 million in FY2021 (+79.6%).
  • The Q2 2026 figure ranks as the highest quarterly Change in Accrued Expenses in data going back to Q1 2019.
  • Year over year, Change in Accrued Expenses gained in four of the last five quarters, with growth averaging 192.8%.
  • The high point for year-over-year Change in Accrued Expenses in five years was Q2 2026 (growth of 415.6%); the low point was Q3 2021 (a decline of 53.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$16.74 million (Q1 2026), $54.6 million (Q4 2025) and $45.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 2.41 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 983.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Revolution Medicines 41.45 Bn 29.93 Bn 197.23 Mn 106.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 106.94 Mn
Jun 30, 2026 55.78 Mn
Mar 31, 2026 -16.74 Mn
Dec 31, 2025 54.60 Mn
Sep 30, 2025 45.29 Mn
Jun 30, 2025 10.82 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 18.30 Mn
Sep 30, 2024 10.28 Mn
Jun 30, 2024 14.67 Mn
Mar 31, 2024 -21.26 Mn
Dec 31, 2023 -6.29 Mn
Sep 30, 2023 7.58 Mn
Jun 30, 2023 15.13 Mn
Mar 31, 2023 -1.75 Mn
Dec 31, 2022 -2.97 Mn
Sep 30, 2022 -1.30 Mn
Jun 30, 2022 7.88 Mn
Mar 31, 2022 -2.11 Mn
Dec 31, 2021 3.74 Mn
API Access

Revolution Medicines Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY